What is already known about this topic? Indoor fine particulate air pollution (PM 2.5 ) is associated with higher asthma morbidity in urban children; factors modifying susceptibility to PM's respiratory effects are unknown. Growing epidemiologic and mechanistic evidence links vitamin D status and asthma.
BACKGROUND: Indoor fine particulate air pollution (PM 2.5 ) is linked to asthma morbidity; however, whether vitamin D status influences individual susceptibility to airborne exposures is unclear. OBJECTIVE: We aimed to determine if vitamin D modifies the effects of indoor PM 2.5 on asthma symptoms in urban children. METHODS: A total of 120 children aged 5 to 12 years with physician-diagnosed asthma were evaluated at baseline and every 3 months for 9 months. Indoor PM 2.5 , serum 25-hydroxy vitamin D (25-OH D) levels, and asthma symptoms were simultaneously assessed at each time point. Adjusting for confounders, generalized estimating equations assessed the 3-way interaction effects of 25-OH D, obesity, and PM on asthma symptoms.
RESULTS: Children were of mean (standard deviation [SD]) age 9.7 (2.2) years, 36% were obese, and 95% self-reported black race. Mean (SD) PM 2.5 indoor exposure was 38.2 (42.9) mg/m Asthma is the most common chronic disease of childhood in the United States, 1 with the burden of disease disproportionately affecting urban minority populations such as blacks. [2] [3] [4] Although a variety of environmental factors may explain high asthma morbidity in urban populations, 5, 6 there is strong evidence demonstrating that indoor fine particulate matter (PM 2.5 ) within urban homes of children with asthma contributes to increased respiratory morbidity, including greater symptoms and medication use. 7, 8 Conversely, dietary factors, including intake of food components thought to have antioxidant, antiallergic, or anti-inflammatory properties, have independently been shown to be protective against asthma outcomes.
9-12 Despite these published relationships, whether personal nutritional status influences the susceptibility to the respiratory effects of indoor air pollution in children is unknown. Determining individual protective factors against urban indoor pollution in vulnerable populations may inform public health strategies aimed at mitigating its adverse effects.
Specifically, growing evidence for vitamin D's role in asthma has suggested a link between low 25-hydroxy (25-OH) vitamin D serum levels and worse asthma health in pediatric populations, 13 leading to increased respiratory symptoms and exacerbations, 14, 15 impaired lung function, [16] [17] [18] [19] [20] and hospitalizations. 21 Furthermore, mechanistic studies have suggested the protective effects of vitamin D against both allergic and pollutant-induced airway disease through antioxidant and immune-modulatory pathways. [22] [23] [24] [25] [26] [27] [28] [29] [30] This is especially relevant to black pediatric populations who have the highest rates of vitamin D deficiency in the country, with increasing rates of insufficiency and deficiency over the last 2 decades, 31 likely due to a combination of reduced UV-mediated dermal production and poor dietary intake. 32 Furthermore, urban minority populations, such as blacks, are disproportionately overweight and obese, 33 which not only independently contributes to asthma-related morbidity, [34] [35] [36] but may also enhance the respiratory effects of indoor PM. 37, 38 Taken together, a coincidence of high levels of exposure to urban indoor air pollution, known risks for suboptimal vitamin D status, 32, 39, 40 and greater obesity among blacks raises the question of whether inadequate vitamin D status may render children in such populations more vulnerable to the adverse respiratory effects of indoor pollutant exposures and may help to explain the disproportionate asthma morbidity within this population.
Therefore, the aim of this analysis was to investigate if personal vitamin D status in a predominantly black urban cohort of children with asthma modifies the response to indoor airborne particulate exposures, and if these effects differ by obesity status. We hypothesized that low serum 25-OH vitamin D (25-OH D) levels would be associated with an increased susceptibility to the effects of indoor PM 2.5 on asthma symptoms, and that these effects may be more pronounced in obese children.
METHODS

Study population
Participants were recruited and enrolled from the Domestic Indoor Particulate Matter and Childhood Asthma Morbidity (DISCOVER) study, a longitudinal cohort study of school-aged children aged 5 to 12 years with physician-diagnosed asthma. Children were recruited from Johns Hopkins pediatric outpatient clinic and emergency department encounters, as well as from participant lists from prior asthma studies, and enrolled between January 2009 and January 2015. Children were included in the study if they reported symptoms of asthma and/or reliever medication use in the last 6 months and lived in their current residence in East Baltimore for at least 6 months, and were excluded if they had a current diagnosis of another pulmonary disease or were planning to move to a different residence within the study period. The Johns Hopkins Institutional Review Board approved the study. Each participant had demographic, medication, and asthma severity data, anthropomorphic measurements (to calculate body mass index [BMI] percentile), 41 and spirometric lung function, assessed at a baseline visit. Participants were subsequently followed over 1 week every 3 months over a 9-month period, extending across all 4 seasons.
Environmental assessments: indoor particulate matter
Personal Environmental Monitors (PEMs) (SKC, Inc., Eighty Four, Pa) designed to collect particles 2.5 mm (PM 2.5 ) were placed within participant homes in the room identified by caregivers where the child spent the most time. PEMs were loaded with 37-mm filters (2.0 mm pore-size polytetrafluoroethylene [Teflo] ; Pall Laboratory, Port Washington, NY), deployed for 1 week at each time, and operated at a flow rate of 4 lpm to gravimetrically assess weeklong mean PM 2.5 levels at 3-month intervals. Constant airflow was maintained for integrated sampling using portable sampling pumps (BGI Inc., Waltham, Mass). Flow rate was calibrated before and at the end of sampling using an electronic flow calibrator (Defender; Mesa Labs). PM gravimetric analysis was conducted on a microbalance (XP2U; Mettler Toledo, Inc., Columbus, Ohio) after filters were equilibrated for 24 hours at constant temperature and humidity.
Quantification of serum 25-hydroxy vitamin D
Participants had blood drawn at baseline and every 3 months thereafter during home visits. Batched archived serum vitamin D concentrations were measured at the Clinical Laboratory Improvement Amendments (CLIA)-certified Immunology Laboratory at the Johns Hopkins Hospital using the chemiluminescence immunoassay (DiaSorin, Stillwater, Minn), which measures both vitamin D2 and D3 forms and is reported as a total serum 25-OH D concentration. Within-person mean values and corresponding standard deviations (SDs) were calculated for each individual. In descriptive analyses, vitamin D sufficiency was defined as values >30 ng/mL, 20 to 30 ng/mL as insufficient, and below 20 ng/mL as deficient to be consistent with prior studies of children, 42, 43 especially with asthma; 18, 19 however, given lack of prior information on levels of 25-OH that may modify PM effects on asthma outcomes, continuous values of 25-OH D were used in main analyses.
Asthma assessment
Baseline asthma severity was classified using the National Asthma Education and Prevention Program guidelines 44 and comprised caregiver-provided data regarding respiratory symptoms, medication use, and limitations in activity, as well as spirometric measurements. Lung function parameters were assessed using a portable spirometer (KOKO spirometer, SX model; nSpire Health, Longmont, Colo), in accordance with American Thoracic Society guidelines using established predicted values for forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC). 45, 46 Daytime asthma symptoms (trouble breathing, being bothered, having limitation in activities), nighttime symptoms, and any need for rescue medication (ie, albuterol) use were assessed using a pediatric asthma diary, 47 a validated daily questionnaire completed by the caregiver twice daily over the 1-week period of each study visit as previously described. 48 Daytime symptoms were measured on a 6-point Likert scale and were dichotomized into being absent or present, with composite daytime symptoms representing none versus any positive response across the 3 daily symptoms. Nighttime symptoms included an assessment of the number of awakenings caused by asthma symptoms on a 4-point Likert scale, dichotomized into being absent or present. Allergic sensitization was performed by either allergic skin testing (ALK, Round Rock, Texas) or with serum allergen-specific IgE quantification corresponding to 14 aeroallergens (RAST; Pharmacia Diagnostics AB, Uppsala, Sweden), with atopy defined as a positive sensitization to at least 1 individual allergen (IgE ! 0.35). Peripheral venipuncture was performed during each week of monitoring, and samples were also analyzed for complete blood count and differential.
Statistical analysis
Participants from the DISCOVER cohort were included into the analytic population if they had complete serum 25-OH D and indoor PM measurements. Descriptive analyses were performed to generate standard distributions of means and proportions. Multivariate ordered logistic and linear regression were used to detect cross-sectional associations between within-person mean 25-OH D levels and asthma outcomes (eg, severity, lung function). Associations between individual average 25-OH D and baseline obese status, as well as seasonal differences across all samples, were tested using 1-way analysis of variance (ANOVA). To assess associations between repeated measures of individual vitamin D status and asthma symptoms or neutrophil percentage, generalized estimating equation regression analysis was used to account for intraparticipant correlation of the observations. 49 Three-way interaction regression models were constructed to explore the effect modification of continuous values of 25-OH D on the association between weekly indoor PM exposure, obesity, and daily respiratory symptoms and adjusted for age, sex, caregiver education, inhaled corticosteroid (ICS) use, and season. Subsequently, the modifying effects of 25-OH D levels on the response to PM 2.5 were examined across obesity status (obese vs nonobese). P < .05 were considered to be statistically significant. Analyses were performed using STATA statistical software (version 15, College Station, Texas).
RESULTS
Participant characteristics and indoor PM exposure
One hundred and twenty school-aged children had serum vitamin D levels assessed on at least 1 occasion during the study follow-up period and had complete environmental and respiratory symptom data to comprise the analytic population. Mean (SD) age of participants was 9.7 (2.2) years with 55% boys. BMI across all children was, on average, in the 71% percentile, with 36% qualifying as obese. Participants were classified across a range of asthma severity and almost half of children reported taking ICSs. Average individual indoor PM 2.5 exposure over the 7-day monitoring periods across visits had a mean (SD) of 38.2 (42.9) mg/m 3 (Table I ). There were no significant differences between the analytic group of 120 children and the overall cohort with respect to age, sex, race, household income, BMI percentile, asthma severity, lung function, or PM exposure (Table E1 , available in this article's Online Repository at www. jaci-inpractice.org).
25-OH D levels
Within-person averages of 25-OH D across all visits in this cohort were distributed around a mean (SD) of 19.1 (7.5) ng/mL; withinperson variability was 5.2 ng/mL (Table E2 , available in this article's Online Repository at www.jaci-inpractice.org). Serum levels did not differ significantly between nonobese versus obese groups (1-way ANOVA between groups P ¼ .98). Almost two-thirds of children 
Independent association of serum 25-OH D and asthma health
The relationship between 25-OH D within-person mean levels and baseline asthma severity and lung function is illustrated in Table II . There was no significant association between vitamin D status and severity classification; however, significant positive associations were found between personal 25-OH D levels and baseline lung function (coefficient 0.519; P ¼ .029 for FVC % predicted), translating to an approximately 5% increase in FVC % predicted for a 10 ng/mL increase in 25-OH D. There was also suggestion of a significant relationship between increasing serum 25-OH D and lower FEV 1 /FVC, possibly due to the effect of vitamin D on higher FVC. Sensitivity analysis with models including ICS use and/or season did not significantly change these results (data not shown). In contrast, in adjusted models including data across all repeated visits, there was no statistically significant association between serum 25-OH D levels and recorded asthma symptoms (Table E3 , available in this article's Online Repository at www.jaci-inpractice.org). Adjusting for lung function (FEV 1 ) in sensitivity analysis illustrated similar nonsignificant relationships.
Interaction of 25-OH D levels on PM 2.5 and asthma symptoms
Given the literature supporting the independent effects of vitamin D status, obesity, and air pollution individually on asthma symptoms, we constructed 3-way interaction models for the regression of symptoms on serum 25-OH D, obesity, and fine PM and found statistically significant interaction effects for all individual asthma symptoms, nighttime symptoms, and rescue medication use (data not shown). Based on these fully adjusted 3-way interaction models and holding obesity status constant, 2-way interactions demonstrated that lower serum 25-OH D levels augmented the adverse relationship between PM 2.5 and limited activity (P int ¼ .003), trouble breathing (P int ¼ .054), feeling bothered by asthma (P int ¼ .030), having any daytime symptoms (P int ¼ .006), nighttime symptoms (P int ¼ .034), and needing rescue medication (P int ¼ .032) among obese children. Among nonobese children, there were no significant 2-way interactions (Table E4 , available in this article's Online Repository at www.jaci-inpractice.org).
Notably, among obese children, the adverse effects of PM 2.5 on daytime asthma symptoms were increased and statistically significant at low 25-OH D levels (odds ratio [OR] PM2.5 ¼ 1.26, P ¼ .049 for vitamin D ¼ 15.5 ng/mL). PM 2.5 had an increasingly stronger effect on daytime asthma symptoms at decreasing levels of vitamin D below 15.5 ng/mL (Figure 1, A) . Among nonobese children, vitamin D status did not modify PM's effect on the risk of daytime asthma symptoms (Figure 1,  B) . Similarly, the adverse effects of PM 2.5 on nighttime asthma symptoms were observed at low 25-OH D levels (<16.4 ng/mL) among obese, but not nonobese, children ( Figure 1, C and D) . Consistent with these results, at extreme levels of indoor air particulate pollution, higher vitamin D levels were found to be significantly protective against increased odds of daytime asthma symptoms associated with PM 2. 
Modifying effect of 25-OH D levels on the association of PM 2.5 and systemic inflammation
To investigate whether serum 25-OH D levels might influence the association between PM 2.5 and peripheral leukocytes and their subtypes, as a reflection of systemic inflammation, we constructed 3-way interaction adjusted models for the regression of peripheral cell counts on serum 25-OH D, obesity, and fine PM. There was no statistically significant adjusted interaction of 25-OH D on PM 2.5 and total white blood cell or absolute neutrophil counts (data not shown). However, a 3-way interaction effect was noted for peripheral neutrophil percentage, and the 2-way interaction suggested as significant for obese children only (P int ¼ .056). Among the obese, PM 2.5 was associated with a significantly greater increase in neutrophil percentage as the vitamin D level decreased (eg, b coefficient ¼ 0.47 for each 10 mg/m 3 increase in PM 2.5 , P ¼ .049 at 25-OH D ¼ 26.8 ng/mL, with increasingly stronger effects <26.8 ng/mL) ( Figure 3 ). For example, at median 25-OH D levels of 18 ng/mL in this subgroup, neutrophil percentages were increased by 2.12 (P < .001) for every 10 mg/m 3 increase in fine PM, and at even lower levels (eg, 25th percentile), the predicted change in neutrophil percentage was 2.78 (P < .001). There was no significant effect of lower levels of 25-OH D on PM 2.5 -associated changes in peripheral neutrophil percentage among nonobese children.
DISCUSSION
This is the first population study to demonstrate that personal vitamin D status in urban children with asthma modifies the risk of respiratory symptoms associated with indoor air pollution. Specifically, we found that serum 25-OH D levels below 15.5 ng/mL increased individual susceptibility to the respiratory effects of indoor air pollution, particularly in obese children. Conversely, higher levels of serum 25-OH D conferred a protective effect against pollutant-associated symptoms in this subgroup. Our findings have direct public health implications for potential strategies to improve the resilience of vulnerable populations against the adverse effects of urban indoor air pollution. Vitamin D has been described in several studies to have independent effects on inflammatory processes responsible for asthma morbidity; 24, 28, 50, 51 however, an immune-modulatory role in response to air pollution has been underexplored. Inflammatory responses to ambient particulate air pollution exposure alone have been shown to generate a systemic reaction through mechanisms that enhance bone-marrow release of polymorphonuclear leukocytes into the peripheral circulation. [52] [53] [54] Analysis within our study, performed to elucidate potential mechanisms through which vitamin D could be influencing such pollutant-induced asthmatic responses, revealed that low 25-OH D levels significantly enhanced the marginal effects of PM 2.5 on the neutrophilic composition of peripheral blood. Such preliminary findings suggest that suboptimal vitamin D status might increase the odds of environmental asthma symptoms through inflammatory pathways. In fact, in vitro studies examining the effects of organic dust inhalation on neutrophil chemokine induction in both human and murine cells have demonstrated that the proinflammatory response is attenuated in cells pretreated with vitamin D, as well as in mice fed a high vitamin D diet compared with those fed a low vitamin D diet. 29 These results suggest a role of vitamin D in mediating air pollutant-induced airway inflammatory response through the modulation of neutrophil chemoattractants. Therefore, our study represents an epidemiologic correlate highlighting similar modifying effects of varying vitamin D status within a population of high-risk, exposed children with asthma.
In our study population, a significant proportion of children had serum 25-OH D levels that would be categorized as deficient, with 89% of children demonstrating suboptimal vitamin D status, according to thresholds prescribed for bone health. This degree of deficiency is consistent with published national high rates of deficiency among blacks. 31 As there are no established thresholds for deficiency and insufficiency specifically relevant for allergic/asthmatic disease, we employed continuous values in our analyses and showed that the marginal effects of PM 2.5 on asthma symptoms became statistically significant below the traditionally defined deficiency of 20 ng/mL (15.5), with dose-dependent effects below this cutoff. Similarly, approximate ranges of 25-OH D for which marginal effects of PM 2.5 on neutrophil percentage were found to be significant fell below the traditional threshold of sufficiency of 30 ng/mL (26.8). Accordingly, in our cohort composed predominantly of black children demographically at risk to have serum levels below these thresholds, lower vitamin D status was not only associated with lower lung function, as published by others, 18, 20, 55 but more importantly, enhanced the clinical and inflammatory asthmatic responses to indoor particulate pollution. These novel findings support the concept that a prescription for global optimal serum vitamin D levels may be a misguided goal, and thresholds of sufficiency may instead need to be tailored according to particular subpopulations of children 56 and/or with regard to specific health outcomes.
Notably, the interaction relationships observed in our cohort were only identified for obese children. The reasons for this are unclear. Similar to our findings, Lautenbacher et al 55 reported that within their cohort of African American and Hispanic children, lung function parameters were found to be lower in the subset of children with both vitamin D deficiency and obesity, but not among normal-weight children with asthma, thereby implying a synergistic role for obesity and vitamin D for asthma morbidity. Our results validate and extend this literature further to asthma symptoms within a similar urban minority subpopulation. The current literature supports relationships that triangulate obesity, inadequate vitamin D, and ambient pollutants together, though the directionality of each association is not well understood. 57 Several hypotheses have been put forth as possible underlying mechanisms for these complex interrelationships, including obesity-mediated vitamin D bioavailability (possibly due to fat sequestration of this vitamin), 58 microbiome alterations influencing vitamin Deregulated gut immune function, 59, 60 and inflammation or metabolic dysregulation found in vitamin Dedeficient individuals, 61 all of which may reflect vitamin D's direct and indirect immune-protective roles in asthma-related outcomes. Further studies are needed to disentangle these coexistent factors among minority populations and gain a better understanding on how they may jointly contribute to asthma-related morbidity in susceptible children.
Our study has several strengths. Our particular cohort of children in Baltimore represents a demographic that uniquely has high risks for obesity, vitamin D deficiency, and indoor air pollution, and manifests a heavy burden of asthma. In addition, repeated measures of serum 25-OH D in each child allowed for a robust appreciation of interactions observed with time-varying concurrent changes in pollutant exposures and asthma control. Our findings warrant replication in future larger cohorts to provide further definitive evidence that vitamin D status and obesity can influence the impact of air pollutants on childhood asthma morbidity. Limitations in our work include the inability to generalize our findings to other urban populations, for example, Hispanic children who also share a heavy burden of asthma. Our findings are hypothesis generating, but we did not do correction for multiple testing and findings should be confirmed in a larger group of subjects. Furthermore, although we have used traditional measures of vitamin D status that measure serum levels of 25-OH D, we were unable to test for other related markers such as blood levels of vitamin D receptor binding protein or other vitamin D metabolites that may have independent effects on the asthmatic response to inhaled toxins. 62 Consideration of the entire vitamin D pathway involved in the protective relationships illustrated by our findings is critical to identify important targets for future therapeutic interventions aimed at reducing the burden of asthma symptoms.
In conclusion, this is the first report to demonstrate that vitamin D increases the susceptibility to the adverse effects of indoor air pollution among obese children with asthma. The protective effects of increasing vitamin D toward asthma symptoms within this population were observed in highly polluted urban homes. These results offer hope for potential future strategies to combat the hazards of environmental pollutants faced by vulnerable populations. 25-OH, 25-Hydroxy; BMI, body mass index; CI, confidence interval; GEE, generalized estimating equation; ICS, inhaled corticosteroid; OR, odds ratio. Bold indicates statistical significance (P < .05). *GEE with AR1 correlation structure, logit link, and robust standard error estimator is used. †The model is adjusted by age, sex, caregiver education, season, and ICS use. zAll models with interaction terms include the necessary lower order interaction and main effect terms. xObesity is dichotomous and based on BMI category for obesity. The 2-way result for the nonobese is based on the 3-way model, holding obesity status at "nonobese." The 2-way result for the obese is based on the 3-way model, holding constant the obesity status at "obese."
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{The coefficient represents OR for 10 mg/m 3 change in PM 2.5 .
